D. Jullien

11.2k total citations · 1 hit paper
171 papers, 6.7k citations indexed

About

D. Jullien is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, D. Jullien has authored 171 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Immunology, 64 papers in Dermatology and 28 papers in Rheumatology. Recurrent topics in D. Jullien's work include Psoriasis: Treatment and Pathogenesis (83 papers), Dermatology and Skin Diseases (45 papers) and Autoimmune Bullous Skin Diseases (15 papers). D. Jullien is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (83 papers), Dermatology and Skin Diseases (45 papers) and Autoimmune Bullous Skin Diseases (15 papers). D. Jullien collaborates with scholars based in France, United States and United Kingdom. D. Jullien's co-authors include C. Paul, F. Aubin, Robert L. Modlin, P. Joly, Michel Le Maître, S. Aractingi, B. Cribier, L. Misery, M.‐A. Richard and Koichi Uyemura and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

D. Jullien

152 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

2018 444 citations D. Jullien et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Jullien France	47	4.2k	2.0k	1.4k	825	648	171	6.7k
Jashin J. Wu United States	42	4.9k 1.2×	2.9k 1.5×	1.6k 1.2×	877 1.1×	711 1.1×	375	7.6k
Emanual Maverakis United States	39	2.2k 0.5×	1.5k 0.8×	626 0.5×	942 1.1×	1.5k 2.3×	183	6.1k
David M. Pariser United States	45	2.5k 0.6×	4.0k 2.0×	747 0.5×	1.8k 2.2×	382 0.6×	220	7.3k
Werner Aberer Austria	56	1.8k 0.4×	4.4k 2.2×	1.9k 1.4×	533 0.6×	760 1.2×	290	10.5k
Lone Skov Denmark	58	6.6k 1.6×	5.5k 2.8×	1.9k 1.4×	924 1.1×	1.4k 2.1×	389	12.9k
Neil J. Korman United States	46	5.6k 1.3×	4.0k 2.0×	2.5k 1.8×	940 1.1×	777 1.2×	163	9.8k
Robert Bissonnette Canada	61	4.6k 1.1×	7.1k 3.6×	2.2k 1.6×	1.4k 1.7×	815 1.3×	304	11.4k
Mariana Castells United States	59	3.6k 0.8×	2.0k 1.0×	2.7k 1.9×	248 0.3×	728 1.1×	228	10.3k
Michael Bigby United States	30	1.2k 0.3×	1.1k 0.5×	410 0.3×	471 0.6×	799 1.2×	102	4.9k
Piergiacomo Calzavara‐Pinton Italy	41	1.2k 0.3×	3.1k 1.6×	647 0.5×	2.4k 3.0×	694 1.1×	305	6.6k

Countries citing papers authored by D. Jullien

Since Specialization

Citations

This map shows the geographic impact of D. Jullien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Jullien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Jullien more than expected).

Fields of papers citing papers by D. Jullien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Jullien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Jullien. The network helps show where D. Jullien may publish in the future.

Co-authorship network of co-authors of D. Jullien

This figure shows the co-authorship network connecting the top 25 collaborators of D. Jullien. A scholar is included among the top collaborators of D. Jullien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Jullien. D. Jullien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Augustin, Matthias, Juliet N. Barker, Curdin Conrad, et al.. (2025). Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of Life. Dermatology and Therapy. 15(7). 1915–1929. 1 indexed citations

Schäkel, Knut, Kristian Reich, K. Asadullah, et al.. (2023). Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb randomized, double‐blind, parallel‐group, GUIDE study. Journal of the European Academy of Dermatology and Venereology. 37(10). 2016–2027. 46 indexed citations

Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2023). Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort. Annales de Dermatologie et de Vénéréologie. 150(2). 101–108. 1 indexed citations

Jullien, D., et al.. (2023). Flare Frequency and Duration in Patients with Generalized Pustular Psoriasis (GPP). SKIN The Journal of Cutaneous Medicine. 7(6). s246–s246.

Jullien, D., Azura Mohd Affandi, H. Turki, et al.. (2023). 186 Real-world clinical characteristics and treatment practices in generalized pustular psoriasis as seen in a chart review (SCRIPTOR). Journal of Investigative Dermatology. 143(11). S363–S363. 1 indexed citations

Houmadi, Raïssa, Nadine Serhan, M. Tauber, et al.. (2023). 3D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System. Science Advances. 9(23). eadf9491–eadf9491. 6 indexed citations

Kanitakis, Jean, Nicolas Fournier, & D. Jullien. (2022). Follicular Porokeratoma: Report of a New Variant of Porokeratoma (Porokeratotic Acanthoma) and Literature Review. American Journal of Dermatopathology. 44(10). 748–752. 2 indexed citations

Lesort, Cécile, et al.. (2021). Cutaneous calciphylaxis of the glans penis presenting as a gangrenous ulceration. Dermatology Online Journal. 27(3). 2 indexed citations

Cordel, N., C. Cassius, D. Jullien, et al.. (2021). La dermatomyosite à type de pseudo dermatite séborrhéique est-elle associée à une pneumopathie interstitielle diffuse ?. 1(8). A113–A113.

10.

Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2021). Impact de l’épidémie de COVID-19 lors de la 1ère vague sur les patients de la cohorte PSOBIOTEQ traités pour psoriasis cutané. PubMed Central. 1(8). A298–A299. 1 indexed citations

11.

Villani, A., F. Amatore, M. Tauber, et al.. (2020). Impact of the French guidelines on the prescribing habits of systemic treatments for moderate‐to‐severe psoriasis. Journal of the European Academy of Dermatology and Venereology. 34(11). e747–e748. 2 indexed citations

12.

Villani, A., Stéphanie Boutroy, Marie-Christine Carlier, et al.. (2020). Distal phalangeal bone erosions observed by HR-pQCT in patients with psoriatic onycholysis. Lara D. Veeken. 60(3). 1176–1184. 8 indexed citations

13.

Debarbieux, S., et al.. (2014). Acrodermatitis Continua of Hallopeau Treated Successfully with Ustekinumab and Acitretin after Failure of Tumour Necrosis Factor Blockade and Anakinra. Dermatology. 230(2). 97–100. 25 indexed citations

14.

Brenaut, E., C. Horreau, Claire Pouplard, et al.. (2013). Alcohol consumption and psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 27(s3). 30–35. 118 indexed citations

15.

Horreau, C., Claire Pouplard, E. Brenaut, et al.. (2013). Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 27(s3). 12–29. 243 indexed citations

16.

Sbidian, É., A. Maza, Henri Montaudié, et al.. (2011). Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 25(s2). 28–33. 49 indexed citations

17.

Sieling, Peter A., María Teresa Ochoa, D. Jullien, et al.. (2000). Evidence for Human CD4+ T Cells in the CD1-Restricted Repertoire: Derivation of Mycobacteria-Reactive T Cells from Leprosy Lesions. The Journal of Immunology. 164(9). 4790–4796. 67 indexed citations

18.

Bonish, Brian K., D. Jullien, Yves Dutronc, et al.. (2000). Overexpression of CD1d by Keratinocytes in Psoriasis and CD1d-Dependent IFN-γ Production by NK-T Cells. The Journal of Immunology. 165(7). 4076–4085. 181 indexed citations

19.

Libraty, Daniel H., Koichi Uyemura, D. Jullien, et al.. (1997). Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy.. Journal of Clinical Investigation. 99(2). 336–341. 78 indexed citations

20.

Jullien, D., et al.. (1993). Alpha interferon treatment in atopic dermatitis.. Acta Dermato Venereologica. 73(2). 130–132. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact